Perseus Biotech Fund Partners LLC

This profile gathers the share dealings of Perseus Biotech Fund Partners LLC in MAP Pharmaceuticals, Inc. The record holds 12 filings, for trades running from 11 October 2007 to 11 May 2010.

Market trades split into 1 purchase (€1.5M) and 4 sales (€300k). On balance, insiders were net buyers of €1.2M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2010: no purchases and 4 sales on the market.

The newest entry dates from 13 May 2010: a transaction, in MAP Pharmaceuticals, Inc. The most recent open-market purchase was published on 12 October 2007, 6,968 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.